Dr. John Cush RheumNow
5 years 9 months ago
#Bestof2020
New EULAR/ACR Classification Criteria for SLE
https://t.co/FWpDmIf6gc https://t.co/MSeNojAEIN
Dr. John Cush RheumNow
5 years 9 months ago
#BestOf2020
ACR 2020 Reproductive Guidelines - Medication Use with Pregnancy
https://t.co/ydfjaN00RS https://t.co/4hOBtor5p5
Dr. John Cush RheumNow
5 years 9 months ago
#Bestof2020 ACR 2020 Reproductive Guidelines - Lactation Guidance
https://t.co/i0UzE2LbzV https://t.co/s5GfvjTOo6
Dr. John Cush RheumNow
5 years 9 months ago
#BestACR20Tweets
Danish Registry study of 12,185 Chronic Urticaria patients shows an overrepresentation mastocytosis and anaphylaxis, as well as atopic dermatitis, rheumatoid arthritis, SLE, thyroiditis and vitiligo https://t.co/sjmf4sSStB
Annals of Rheumatic Disease reports on an analysis of lupus (SLE) patients that shows COVID-19 infection rates were similar between those lupus patients who were taking hydroxychloroquine (HCQ) and those not taking HCQ.
JAMA has published a clinical update of recent studies on GCA. While PET/CT scanning are novel means of demonstrating activity, they have not changed the diagnostic approach to GCA or PMR and although there are no new proven treatment strategies for PMR beyond glucocorticoids, the FDA has approved tocilizumab as a first-line glucocorticoid-sparing agent.
Dr. John Cush RheumNow
5 years 9 months ago
#BestACR20Tweets
"Few men are willing to brave the disapproval of their fellows, the censure of their colleagues, the wrath of their society. Moral courage is ... the one essential, vital quality for those who seek to change the world which yields most painfully to change" -RFK
Dr. John Cush RheumNow
5 years 9 months ago
#BestACR20Tweets
Canadian study of 643 pts triaged for a positive ANA; 41% were seen by a rheumatologist. 1) 24% of ANA+ ps had an ANA assoc rheumatic dz (AARD); 2) 26%no evidence of any disease; 3) 39% other rheum Dx4) 11% failed to met AARD criteria. https://t.co/9BwUtqUOWk
Dr. John Cush RheumNow
5 years 9 months ago
Panelists Dr. Richard Conway, Dr. David Liew, Dr. Sarah Mackie and Dr. Len Calabrese discuss giant cell arteritis studies presented at #ACR20.
https://t.co/hj0UyIxMUl
Dr. John Cush RheumNow
5 years 9 months ago
Listen to the RheumNow podcast where we look back at #ACR20
https://t.co/M3zJ0tzIPz https://t.co/zPwNtomf1K
Dr. John Cush RheumNow
5 years 9 months ago
Red Flags and Detours -- New RA Guidelines: Dr. Jack Cush dons his bullet-proof vest before taking aim at the new ACR RA Guidelines at presented at #ACR20.
https://t.co/ZhfCiP59Qu https://t.co/0VUczI7pXu
Dr. John Cush RheumNow
5 years 9 months ago
Download our document titled "Difficult RA Defined"
https://t.co/6WGMEiwiUk https://t.co/FFoAn08tjC
Dr. John Cush RheumNow
5 years 9 months ago
Registration is now open for RheumNow Live on March 20 and 21st. Register today!
https://t.co/vJlU0Z3Q3x
The ACR has published guidelines to manage reproductive health issues in rheumatic disease (RMD) patients before, during and after pregnancy. In this second excerpt from their guidelines articles, we present recommendations (and good clinical practice statements) for paternal rheumatology medication use by men with RMD and on conventional rheumatology medications and biologic use in pregnancy for women with RMD.
In this third excerpt from the ACR guidelines on managing reproductive health issues in rheumatic disease patients, we present recommendations regarding the use of glucocorticoids and guidance on lactation and medication use post-partum.
